Future work could leverage serum/plasma proteome data sets, and the SNPs subsequently predicting a given protein’s serum level, to investigate both association and directionality of serum IL-1R2 level and diseases, including IBD. The gene discussed is IL1R2; the disease is inflammatory bowel disease.